Bayer Aktiengesellschaft Stock Other OTC
Equities
BAYRY
US0727303028
Pharmaceuticals
Sales 2024 * | 46.99B 51.07B | Sales 2025 * | 47.76B 51.9B | Capitalization | 26.17B 28.44B |
---|---|---|---|---|---|
Net income 2024 * | 2.33B 2.54B | Net income 2025 * | 3.29B 3.57B | EV / Sales 2024 * | 1.27 x |
Net Debt 2024 * | 33.42B 36.32B | Net Debt 2025 * | 30.23B 32.85B | EV / Sales 2025 * | 1.18 x |
P/E ratio 2024 * |
11.2
x | P/E ratio 2025 * |
7.92
x | Employees | - |
Yield 2024 * |
0.41% | Yield 2025 * |
0.41% | Free-Float | 99.97% |
Latest transcript on Bayer Aktiengesellschaft
Managers | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
Director of Finance/CFO | 55 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Alberto Weisser
BRD | Director/Board Member | 68 | 21-03-31 |
Paul Achleitner
BRD | Director/Board Member | 67 | 02-03-31 |
1st Jan change | Capi. | |
---|---|---|
+60.25% | 846B | |
+38.56% | 628B | |
-4.49% | 360B | |
+18.30% | 322B | |
+9.64% | 297B | |
+14.15% | 240B | |
+3.11% | 224B | |
+16.98% | 223B | |
+12.87% | 173B |